Skip to main content
. 2021 Nov 24;9(12):1625. doi: 10.3390/healthcare9121625

Table 1.

Demographic characteristics of HIV-infected patients, with or without efavirenz therapy, 2000–2009.

Variables Efavirenz-Treated Group (n = 4047) Non-Efavirenz Treated Group (n = 3239) p Value
Gender 0.282
Male 3777 (93.3) 3043 (93.9)
Female 270 (6.7) 196 (6.1)
Age of HIV diagnosis, years 35.0 (20–81, 10.4) 35.1 (20–81, 10.6) 0.658
20–29 1453 (35.9) 1209 (37.3) 0.554
30–39 1561 (38.6) 1191 (36.8)
40–49 654 (16.2) 521 (16.1)
50–59 257 (6.3) 219 (6.7)
≥60 122 (3.0) 99 (3.1)
Residence area <0.001
North 2109 (52.1) 2037 (62.9)
Central 667 (16.5) 455 (14.0)
South 1121 (27.7) 628 (19.4)
East and outer islands 150 (3.7) 119 (3.7)
Insurance premium based monthly income, NTD 0.005
≤17,280 1940 (47.9) 1488 (45.9)
17,281–26,400 1058 (26.2) 790 (24.4)
26,401–43,900 649 (16.0) 591 (18.3)
≥43,901 400 (9.9) 370 (11.4)
Comorbidities
Opportunistic infections 2268 (56.0) 1675 (51.7) <0.001
Hypertension 147 (3.6) 129 (4.0) 0.436
Diabetes mellitus 93 (2.3) 84 (2.6) 0.416
Cardiovascular diseases 26 (0.6) 32 (0.9) 0.099
Psychiatric disorders
(other than depressive disorders)
239 (5.9) 208 (6.4) 0.362
Observation time, mean
(range, SD), years
6.1 (0–11, 3.9) 4.7 (0–11, 3.16) <0.001
Depressive disorders 304 (7.5) 191 (5.9) <0.001

NTD = New Taiwan Dollar; SD = Standard deviation.